LDLR and atherosclerosis: The same laboratory subsequently developed another atheroprone HGPS model, the Ldlr−/−LmnaG609G/G609G mouse [59], which harbors the progerin-causing Lmna mutation and ablation of the LDL receptor gene (Ldlr), another well-established strategy for inducing atherosclerosis in mice [66].